Global prevalence of metabolic syndrome in patients with Rheumatoid arthritis: a systematic review and meta-analysis

Abstract Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder that increases the risk of systemic complications, particularly metabolic syndrome (MetS). MetS, defined by central obesity, hypertension, hyperglycemia, and dyslipidemia, not only raises cardiovascular risk but also wors...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maryam Jafari, Kishan Patel, Abinash Mahapatro, Bita Amirian, Casra Saeedi, Satabdi Sahu, Mohit Mirchandani, Herby Jeanty, Elan Mohanty, Nakka Raghuma, Saisree Reddy Adla Jala, Shika M Jain, Pavan Devulapally, Rahman Hameed Mohammed Abdul, Pegah Rashidian, Negin Letafatkar, Farahnaz Joukar, Forough Heidarzad, Mohammad-Javad Khosousi, Mohammad Amin Karimi, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-10-01
coleção:	BMC Rheumatology
Assuntos:	Cardiovascular risk Dyslipidemia Metabolic syndrome Rheumatoid arthritis Screening
Acesso em linha:	https://doi.org/10.1186/s41927-025-00572-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!